Literature DB >> 22541506

Prevalence of respiratory disorders in veal calves and potential risk factors.

M Brscic1, H Leruste, L F M Heutinck, E A M Bokkers, M Wolthuis-Fillerup, N Stockhofe, F Gottardo, B J Lensink, G Cozzi, C G Van Reenen.   

Abstract

The study aimed to assess the in vivo and postmortem prevalence of respiratory disorders in veal calves and investigate risk factors associated with them. A cross-sectional study was carried out in 174 farms in the 3 major veal meat-producing countries in Europe (50 in France, 100 in the Netherlands, and 24 in Italy). Trained veterinarians visually evaluated individual calves of 1 batch per farm at 3 and 13 wk after arrival and at 2 wk before slaughter to assess the prevalence of hampered respiration, nasal discharge, and coughing. A random sample of lungs belonging to calves of the same batch was monitored at the slaughterhouse for mild to moderate or severe signs of pneumonia, and presence of pleuritis. Data regarding veal calf housing, feeding, and management and specific characteristics of the batch were collected through an interview with the stockperson, and the potential of these as respiratory disease risk factors was assessed. Regardless of the stage of fattening, the prevalence of in vivo signs of respiratory disorders in calves was always <7%. This low prevalence was likely the outcome of the general implementation by veal producers of standardized practices such as prophylaxis, all-in/all-out, and individual daily checks of the calves, which are recognized tools for effective disease prevention and management. However, at postmortem inspection, 13.9% and 7.7% of lungs showed mild to moderate and severe signs of pneumonia, respectively, and 21.4% of the inspected lungs had pleuritis. Thus, even mild clinical signs of respiratory disorder in calves at specific time points during the fattening period may be associated with high prevalence of lungs with lesions at slaughter. Alternatively, clinical symptoms recorded during routine visual inspections of veal calves on-farm may be poor predictors of the true prevalence of respiratory disease in calves. Among all potential risk factors considered, those concerning the characteristics of the batch were predominant but factors related to housing, management and feeding equipment were also relevant. Different risk factors were involved at different stages of the fattening period. Therefore, to overcome respiratory disorders in veal calves, different solutions may apply to different stages of the fattening period.
Copyright © 2012 American Dairy Science Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22541506     DOI: 10.3168/jds.2011-4699

Source DB:  PubMed          Journal:  J Dairy Sci        ISSN: 0022-0302            Impact factor:   4.034


  18 in total

1.  Risk factors for poor health outcomes for male dairy calves undergoing transportation in western Canada.

Authors:  Devon J Wilson; Jane Stojkov; David L Renaud; David Fraser
Journal:  Can Vet J       Date:  2020-12       Impact factor: 1.008

2.  Welfare of cattle during transport.

Authors:  Søren Saxmose Nielsen; Julio Alvarez; Dominique Joseph Bicout; Paolo Calistri; Elisabetta Canali; Julian Ashley Drewe; Bruno Garin-Bastuji; Jose Luis Gonzales Rojas; Christian Gortázar Schmidt; Virginie Michel; Miguel Ángel Miranda Chueca; Barbara Padalino; Paolo Pasquali; Helen Clare Roberts; Hans Spoolder; Karl Stahl; Antonio Velarde; Arvo Viltrop; Christoph Winckler; Bernadette Earley; Sandra Edwards; Luigi Faucitano; Sonia Marti; Genaro C Miranda de La Lama; Leonardo Nanni Costa; Peter T Thomsen; Sean Ashe; Lina Mur; Yves Van der Stede; Mette Herskin
Journal:  EFSA J       Date:  2022-09-07

3.  A randomised clinical trial of a metaphylactic treatment with tildipirosin for bovine respiratory disease in veal calves.

Authors:  J Berman; D Francoz; J Dubuc; S Buczinski
Journal:  BMC Vet Res       Date:  2017-06-14       Impact factor: 2.741

Review 4.  Evaluating Potential Biomarkers of Health and Performance in Veal Calves.

Authors:  Francesca Marcato; Henry van den Brand; Bas Kemp; Kees van Reenen
Journal:  Front Vet Sci       Date:  2018-06-21

5.  Randomized field trial on the effects of body weight and short transport on stress and immune variables in 2- to 4-week-old dairy calves.

Authors:  Christien Masmeijer; Bert Devriendt; Tina Rogge; Katharina van Leenen; Lieze De Cremer; Bonny Van Ranst; Piet Deprez; Eric Cox; Bart Pardon
Journal:  J Vet Intern Med       Date:  2019-03-25       Impact factor: 3.333

6.  Prediction of respiratory disease and diarrhea in veal calves based on immunoglobulin levels and the serostatus for respiratory pathogens measured at arrival.

Authors:  Bart Pardon; Jeroen Alliët; Randy Boone; Sophie Roelandt; Bonnie Valgaeren; Piet Deprez
Journal:  Prev Vet Med       Date:  2015-04-25       Impact factor: 2.670

7.  Scientific Opinion on the welfare of cattle kept for beef production and the welfare in intensive calf farming systems.

Authors: 
Journal:  EFSA J       Date:  2012-05-15

8.  Impact of respiratory disease, diarrhea, otitis and arthritis on mortality and carcass traits in white veal calves.

Authors:  Bart Pardon; Miel Hostens; Luc Duchateau; Jeroen Dewulf; Koen De Bleecker; Piet Deprez
Journal:  BMC Vet Res       Date:  2013-04-15       Impact factor: 2.741

9.  Characterization of the upper and lower respiratory tract microbiota in Piedmontese calves.

Authors:  Isabella Nicola; Francesco Cerutti; Elena Grego; Iride Bertone; Paola Gianella; Antonio D'Angelo; Simone Peletto; Claudio Bellino
Journal:  Microbiome       Date:  2017-11-21       Impact factor: 14.650

10.  Risk factors associated with exposure to bovine respiratory disease pathogens during the peri-weaning period in dairy bull calves.

Authors:  Gerard M Murray; Simon J More; Tracy A Clegg; Bernadette Earley; Rónan G O'Neill; Dayle Johnston; John Gilmore; Mikhail Nosov; Máire C McElroy; Thomas J Inzana; Joseph P Cassidy
Journal:  BMC Vet Res       Date:  2018-02-27       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.